1 / 5

Allergic Asthma Therapeutics Market Analysis: Growth Challenges, Opportunities

Asthma is a long-term inflammatory lung disease which is caused by inflammation and narrowing in the air passage resulting from environmental and genetic influences.

5186
Download Presentation

Allergic Asthma Therapeutics Market Analysis: Growth Challenges, Opportunities

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Allergic Asthma Therapeutics Market Analysis: Allergic Asthma Therapeutics Market Analysis: Growth Challenges, Opportunities Growth Challenges, Opportunities Asthma is a long-term inflammatory lung disease which is caused by inflammation and narrowing in the air passage resulting from environmental and genetic influences. Allergic asthma is one of the most common types of asthma. Allergic asthma is triggered by inhaling allergens such as mold, pollen, pet dander, and dust mite allergen resulting in symptoms of allergic asthma which include chest tightness, rapid breathing or shortness of breath, wheezing, and coughing. The allergic asthma therapeutics market is estimated to be valued at US$ 6,704.8 million 2020 2020 and is expected to exhibit a CAGR of 2.9% CAGR of 2.9% during the forecast period (2020-2027) US$ 6,704.8 million in (2020-2027). Request for Sample Copy: Request for Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/4019 https://www.coherentmarketinsights.com/insight/request-sample/4019 Market Dynamics Market Dynamics The rising incidence of respiratory diseases and the growing demand for cost-effective treatments are expected to propel the allergic asthma therapeutics market growth in future. Additionally, an increase in pollution levels and an upsurge in cases of chronic obstructive pulmonary diseases (COPD) are other factors boosting the market growth. According to the World Health Organization (WHO), more than 200 million people suffer from COPD and around 235 million have asthma all across the globe. Allergic asthma therapeutics are cost-effective and gaining popularity among patients and healthcare professionals due to launches of novel drugs by key players. This is estimated to drive the market growth during the forecast period. Moreover, governments are taking initiatives to provide better care and treatment for patients, and are focusing on increasing awareness about allergic asthma which is contributing to the allergic asthma therapeutics market growth. However, the increasing use of generic drugs and

  2. upsurge in patent expiry of drugs are predicted to restrict the market growth in the forecast period. Key features of the study: Key features of the study: • This report provides in-depth analysis of the global allergic asthma therapeutics market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year • It elucidates potential revenue opportunity across different segments and explains an attractive investment proposition matrix for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players • It profiles key players in the global allergic asthma therapeutics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and strategies • Key players covered as a part of this study are Aslan Pharmaceuticals Pte. Ltd., Baxalta Incorporated, Axikin Pharmaceuticals, Chiesi Farmaceutici SpA, CSL Limited, Circassia Pharmaceuticals Plc, Fountain Biopharma Inc., Hydra Biosciences, GlaxoSmithKline Plc, Infinity Pharmaceuticals, Mabtech Limited, Kineta, Marinomed Biotechnologie Gmb, NeoPharm Co., Mycenax Biotech Inc., Panacea Biotec Limited, and Oxagen Limited. • Insights from this report would allow marketers and management authorities of companies to make an informed decision with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics • The global allergic asthma therapeutics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for allergic asthma therapeutics market, research and consulting firms, new entrants, and financial analysts. Global Allergic Asthma Therapeutics Market: Restraints Global Allergic Asthma Therapeutics Market: Restraints However, the rising patent expiration of drugs is a major factor which is expected to hamper the growth of the allergic asthma therapeutics market. Also, lower awareness about novel drugs in rural areas of Asia Pacific and Africa are expected to result in slower adoption of allergic asthma therapeutics and hinder growth of the allergic asthma therapeutics market.

  3. Moreover, an increase in the use of generic drugs in such regions is also expected to restrict the growth of the allergic asthma therapeutics market during the forecast period. Global Allergic Asthma Therapeutics Market – Regional Analysis Global Allergic Asthma Therapeutics Market – Regional Analysis North America accounted for majority of share in the global allergic asthma therapeutics market in 2019 owing to the presence of major market players and approvals of novel drugs in the market For instance, in September 2018, Novartis AG received the US Food and Drug Administration (FDA) approval for its prefilled syringe formulation, Xolair (omalizumab). Xolair has been approved for 75 mg and 150 mg single dose for both chronic idiopathic urticaria (CIU) and allergic asthma. Moreover, diagnosis of this condition is critical for an effective treatment regimen. For instance, in September 2019, Genentech and Abionic entered a joint agreement to develop and provide quick point-of-care tests for asthma in the U.S. Genentech is funding the clinical and regulatory costs, whereas, Abionic has managed the pre-market procedure for the specific asthma panel. Furthermore, Asia Pacific is expected to witness significant growth in the global allergic asthma therapeutics market owing to initiatives taken by key players. Companies such as Aslan Pharmaceuticals, Kineta, and others are investing in research and development of novel drugs for allergic asthma. Report includes chapters which deeply display the following deliverable about industry : Report includes chapters which deeply display the following deliverable about industry : • Allergic Asthma Therapeutics Market Research Objective and Assumption • Allergic Asthma Therapeutics Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Allergic Asthma Therapeutics Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Allergic Asthma Therapeutics Market, By Regions • Allergic Asthma Therapeutics Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Allergic Asthma Therapeutics Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Allergic Asthma Therapeutics Market Manufacturing Cost Analysis including Key Raw Materials

  4. and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Allergic Asthma Therapeutics Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion To Get Instant Access, Purchase Report Here @ To Get Instant Access, Purchase Report Here @ https://www.coherentmarketinsights.com/insight/ buy-now/4019 buy-now/4019 https://www.coherentmarketinsights.com/insight/ Global Allergic Asthma Therapeutics Market - Competitive Landscape Global Allergic Asthma Therapeutics Market - Competitive Landscape Key players operating in the global allergic asthma therapeutics market are Aslan Pharmaceuticals Pte. Ltd., Baxalta Incorporated, Axikin Pharmaceuticals, Chiesi Farmaceutici SpA, CSL Limited, Circassia Pharmaceuticals Plc, Fountain Biopharma Inc., Hydra Biosciences, GlaxoSmithKline Plc, Infinity Pharmaceuticals, Mabtech Limited, Kineta, Marinomed Biotechnologie Gmb, NeoPharm Co., Mycenax Biotech Inc., Panacea Biotec Limited, and Oxagen Limited. About Coherent Market Insights About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action- ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Contact Us

  5. Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Phone: US +12067016702 / UK +4402081334027 Email: Email: sales@coherentmarketinsights.com sales@coherentmarketinsights.com

More Related